Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice
- PMID: 10987272
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice
Abstract
Two isoforms of cyclooxygenase (COX) are known, and to date most studies have implicated COX-2, rather than COX-1, as the isoform involved in colon carcinogenesis. In the present study, we show that homologous disruption of either Ptgs-1 or Ptgs-2 (genes coding for COX-1 or COX-2, respectively) reduced polyp formation in Min/+ mice by approximately 80%. Only COX-1 protein was immunohistochemically detected in normal intestinal tissue, whereas both COX-1 and variable levels of COX-2 protein were detected in polyps. Prostaglandin E2 was increased in polyps compared with normal tissue, and both COX-1 and COX-2 contributed to the PGE2 produced. The results indicate that COX-1, as well as COX-2, plays a key role in intestinal tumorigenesis and that COX-1 may also be a chemotherapeutic target for nonsteroidal anti-inflammatory drugs.
Similar articles
-
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.Cancer Res. 2001 Aug 15;61(16):6131-6. Cancer Res. 2001. PMID: 11507063
-
Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.Cancer Res. 2002 Jun 15;62(12):3395-401. Cancer Res. 2002. PMID: 12067981
-
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.Cancer Res. 2001 Feb 15;61(4):1733-40. Cancer Res. 2001. PMID: 11245490
-
The role of cyclooxygenases in inflammation, cancer, and development.Oncogene. 1999 Dec 20;18(55):7908-16. doi: 10.1038/sj.onc.1203286. Oncogene. 1999. PMID: 10630643 Review.
-
Prevention of colorectal cancer through the use of COX-2 selective inhibitors.Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S50-6. doi: 10.1007/s00280-004-0887-x. Cancer Chemother Pharmacol. 2004. PMID: 15309515 Review.
Cited by
-
Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo.Cancer Prev Res (Phila). 2013 May;6(5):466-76. doi: 10.1158/1940-6207.CAPR-12-0358. Epub 2013 Mar 26. Cancer Prev Res (Phila). 2013. PMID: 23531445 Free PMC article.
-
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.Cancers (Basel). 2021 Feb 24;13(5):942. doi: 10.3390/cancers13050942. Cancers (Basel). 2021. PMID: 33668160 Free PMC article. Review.
-
Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.Oncotarget. 2015 May 20;6(14):12310-25. doi: 10.18632/oncotarget.3678. Oncotarget. 2015. PMID: 25987127 Free PMC article.
-
Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis.Virchows Arch. 2004 Dec;445(6):564-71. doi: 10.1007/s00428-004-1104-3. Epub 2004 Sep 14. Virchows Arch. 2004. PMID: 15372235
-
Apoptosis and colorectal cancer.Gut. 2004 Nov;53(11):1701-9. doi: 10.1136/gut.2004.052704. Gut. 2004. PMID: 15479695 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials